Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.392,94
0,09%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SpringWorks Therapeutics Inc (SWTX) SpringWorks Therapeutics Inc (SWTX) Notizie

SWTX

SpringWorks Therapeutics (SWTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SWTX
DataOraFonteTitoloSimboloCompagnia
07/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SWTXSpringWorks Therapeutics Inc
05/06/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
05/06/202413:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
03/06/202422:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
23/05/202423:13GlobeNewswire Inc.SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SWTXSpringWorks Therapeutics Inc
08/05/202413:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
02/05/202412:30GlobeNewswire Inc.SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business UpdatesNASDAQ:SWTXSpringWorks Therapeutics Inc
24/04/202419:31GlobeNewswire Inc.SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SWTXSpringWorks Therapeutics Inc
18/04/202413:00GlobeNewswire Inc.SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024NASDAQ:SWTXSpringWorks Therapeutics Inc
04/03/202412:30GlobeNewswire Inc.SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PNNASDAQ:SWTXSpringWorks Therapeutics Inc
29/02/202414:30GlobeNewswire Inc.SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid TumorsNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202414:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202413:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202412:51Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202412:30GlobeNewswire Inc.SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business UpdatesNASDAQ:SWTXSpringWorks Therapeutics Inc
22/02/202413:00GlobeNewswire Inc.SpringWorks Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:SWTXSpringWorks Therapeutics Inc
14/02/202414:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SWTXSpringWorks Therapeutics Inc
31/01/202413:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
08/01/202412:30GlobeNewswire Inc.SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
21/12/202313:00GlobeNewswire Inc.SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
08/12/202322:05GlobeNewswire Inc.SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SWTXSpringWorks Therapeutics Inc
05/12/202306:32GlobeNewswire Inc.SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common StockNASDAQ:SWTXSpringWorks Therapeutics Inc
04/12/202322:13GlobeNewswire Inc.SpringWorks Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:SWTXSpringWorks Therapeutics Inc
29/11/202313:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
28/11/202313:53Dow Jones NewsSpringWorks Shares Rise on FDA Approval for Tumor TreatmentNASDAQ:SWTXSpringWorks Therapeutics Inc
28/11/202300:46Dow Jones NewsSpringWorks Gets FDA Approval for Desmoid Tumor TreatmentNASDAQ:SWTXSpringWorks Therapeutics Inc
28/11/202300:04GlobeNewswire Inc.SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid TumorsNASDAQ:SWTXSpringWorks Therapeutics Inc
16/11/202312:30GlobeNewswire Inc.SpringWorks Therapeutics Announces Positive Topline Results from the Phase 2b ReNeu Trial of Mirdametinib in NF1-PNNASDAQ:SWTXSpringWorks Therapeutics Inc
02/11/202312:54Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SWTXSpringWorks Therapeutics Inc
02/11/202311:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SWTXSpringWorks Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SWTX

La tua Cronologia

UNSW3
LHINUETH
Love Hate Inu
TG
BTIC
Invesco Digital Markets
EU
1860T
1860T
LSE
0IR7
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network